nach oben

Erschienen in:

01.04.2015 | Original Communication

Abnormal cerebellar volume and corticocerebellar dysfunction in early manifest Huntington’s disease

verfasst von: Robert Christian Wolf, Philipp Arthur Thomann, Fabio Sambataro, Nadine Donata Wolf, Nenad Vasic, G. Bernhard Landwehrmeyer, Sigurd Dietrich Süßmuth, Michael Orth

Erschienen in: Journal of Neurology | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Evidence from animal models and neuropathological data has revealed cerebellar pathology in Huntington’s disease (HD). The extent of cerebellar dysfunction in preclinical stages and in early manifest HD is unclear. In this study, using MRI we investigated cerebellar changes in preclinical (preHD) and early manifest HD individuals. High-resolution structural MRI data at 3 Tesla were obtained from two independent preHD samples (n = 20/25 participants), from two independent cohorts of healthy controls (n = 20/24 participants) and from patients with early manifest HD (n = 20 participants). Resting-state functional MRI data were acquired from 20 healthy controls and 20 HD patients. Cerebellar volume was investigated using cerebellum-optimized voxel-based analysis methods. Corticocerebellar connectivity at rest was investigated by means of seed-region correlations. In both preHD samples, between-group analyses revealed no change of cerebellar volume. In contrast, early manifest HD patients exhibited lower right cerebellar lobule VIIa volume (p < 0.05 cluster-corrected). Within the control group regions functionally coupled to right cerebellar lobule VII comprised bilateral cerebellar regions, right prefrontal and cingulate areas, whereas within manifest HD, functional coupling was found in paracentral, lingual and inferior frontal areas. Paracentral connectivity strength in patients was associated with disease burden and motor symptoms. These data suggest intact cerebellar volume in preHD. In contrast, early manifest HD patients exhibit atrophy of specific cerebellar subregions and abnormal corticocerebellar functional coupling. In early HD, the association between paracentral lobule function and clinical parameters suggests that corticocerebellar connectivity strength is related to the evolution of HD biology and the severity of HD motor signs.

Nur mit Berechtigung zugänglich

Roos RA (2010) Huntington’s disease: a clinical review. Orphanet J Rare Dis 5:40PubMedCentralCrossRefPubMed

Vonsattel JP, Myers RH, Stevens TJ (1985) Neuropathological classification of Huntington’s disease. J Neuropathol Exp Neurol 44:559–577CrossRefPubMed

Vonsattel JP, Keller C, Cortes Ramirez EP (2011) Huntington’s disease—neuropathology. Handb Clin Neurol 100:83–100CrossRefPubMed

Hadzi TC, Hendricks AE, Latourelle JC, Lunetta KL, Cupples LA, Gillis T et al (2012) Assessment of cortical and striatal involvement in 523 Huntington disease brains. Neurology 79:1708–1715PubMedCentralCrossRefPubMed

Kloppel S, Henley SM, Hobbs NZ, Wolf RC, Kassubek J, Tabrizi SJ et al (2009) Magnetic resonance imaging of Huntington’s disease: preparing for clinical trials. Neuroscience 164:205–219PubMedCentralCrossRefPubMed

Wolf RC, Klöppel S (2013) Clinical significance of frontal cortex abnormalities in Huntington’s disease. Exp Neurol 247:39–44CrossRefPubMed

Weir DW, Sturrock A, Leavitt BR (2011) Development of biomarkers for Huntington’s disease. Lancet Neurol 10:573–590CrossRefPubMed

Ross CA, Tabrizi SJ (2011) Huntington’s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10:83–98CrossRefPubMed

Wolf RC, Thomann PA, Thomann AK, Vasic N, Wolf ND, Landwehrmeyer GB et al (2013) Brain structure in preclinical Huntington’s disease: a multi-method approach. Neurodegener Dis 12:13–22CrossRefPubMed

10.

Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D et al (2009) Biological and clinical manifestations of Huntington’s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 8:791–801PubMedCentralCrossRefPubMed

11.

Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R et al (2011) Biological and clinical changes in premanifest and early stage Huntington’s disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol 10:31–42CrossRefPubMed

12.

Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA et al (2013) Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington’s disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol 12:637–649CrossRefPubMed

13.

Hobbs NZ, Henley SM, Ridgway GR, Wild EJ, Barker RA, Scahill RI et al (2010) The progression of regional atrophy in premanifest and early Huntington’s disease: a longitudinal voxel-based morphometry study. J Neurol Neurosurg Psychiatry 81:756–763CrossRefPubMed

14.

Fiez J (1996) Cerebella contributions to cognition. Neuron 16:13–15CrossRefPubMed

15.

Stoodley CJ, Schmahmann JD (2009) Functional topography in the human cerebellum: a meta-analysis of neuroimaging studies. Neuroimage 44:489–501CrossRefPubMed

16.

Strick PL, Dum RP, Fiez JA (2009) Cerebellum and nonmotor function. Annu Rev Neurosci 32:413–434CrossRefPubMed

17.

Buckner RL (2013) The cerebellum and cognitive function: 25 years of insight from anatomy and neuroimaging. Neuron 80:807–815CrossRefPubMed

18.

Papp KV, Kaplan RF, Snyder PJ (2011) Biological markers of cognition in prodromal Huntington’s disease: a review. Brain Cogn 77:280–291CrossRefPubMed

19.

Papoutsi M, Labuschagne I, Tabrizi SJ, Stout JC (2014) The cognitive burden in Huntington’s disease: pathology, phenotype, and mechanisms of compensation. Mov Disord 29:673–683CrossRefPubMed

20.

Dumas EM, van den Bogaard SJ, Middelkoop HA, Roos RA (2013) A review of cognition in Huntington’s disease. Front Biosci (Schol Ed) 5:1–18CrossRef

21.

Fennema-Notestine C, Archibald SL, Jacobson MW, Corey-Bloom J, Paulsen JS, Peavy GM et al (2004) In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease. Neurology 63:989–995CrossRefPubMed

22.

Rosas HD, Koroshetz WJ, Chen YI, Skeuse C, Vangel M, Cudkowicz ME et al (2003) Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology 60:1615–1620CrossRefPubMed

23.

Turmaine M, Raza A, Mahal A, Mangiarini L, Bates GP, Davies SW (2000) Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington’s disease. Proc Natl Acad Sci USA 97:8093–8097PubMedCentralCrossRefPubMed

24.

Dougherty SE, Reeves JL, Lesort M, Detloff PJ, Cowell RM (2013) Purkinje cell dysfunction and loss in a knock-in mouse model of Huntington disease. Exp Neurol 240:96–102PubMedCentralCrossRefPubMed

25.

Tong Y, Ha TJ, Liu L, Nishimoto A, Reiner A, Goldowitz D (2011) Spatial and temporal requirements for huntingtin (Htt) in neuronal migration and survival during brain development. J Neurosci 31:14794–14799PubMedCentralCrossRefPubMed

26.

Rub U, Hoche F, Brunt ER, Heinsen H, Seidel K, Del Turco D et al (2012) Degeneration of the cerebellum in Huntington’s disease (HD): possible relevance for the clinical picture and potential gateway to pathological mechanisms of the disease process. Brain Pathol 23:165–177CrossRefPubMed

27.

Werner CJ, Dogan I, Sass C, Mirzazade S, Schiefer J, Shah NJ et al (2014) Altered resting-state connectivity in Huntington’s disease. Hum Brain Mapp 35:2582–2593CrossRefPubMed

28.

Wolf RC, Vasic N, Schonfeldt-Lecuona C, Ecker D, Landwehrmeyer GB (2009) Cortical dysfunction in patients with Huntington’s disease during working memory performance. Hum Brain Mapp 30:327–339CrossRefPubMed

29.

Novak MJ, Warren JD, Henley SM, Draganski B, Frackowiak RS, Tabrizi SJ (2012) Altered brain mechanisms of emotion processing in pre-manifest Huntington’s disease. Brain 135:1165–1179PubMedCentralCrossRefPubMed

30.

Georgiou-Karistianis N, Stout JC, Dominguez DJ, Carron SP, Ando A, Churchyard A et al (2014) Functional magnetic resonance imaging of working memory in Huntington’s disease: cross-sectional data from the IMAGE-HD study. Hum Brain Mapp 35:1847–1864CrossRefPubMed

31.

Zimbelman JL, Paulsen JS, Mikos AE, Reynolds NC, Hoffman RG, Rao SM (2007) fMRI detection of early neural dysfunction in preclinical Huntington’s disease. J Int Neuropsychol Soc 13:758–769CrossRefPubMed

32.

Scharmüller W, Ille R, Schienle A (2013) Cerebellar contributions to anger recognition deficits in Huntington’s disease. Cerebellum 12:819–825PubMedCentralCrossRefPubMed

33.

Gomez-Anson B, Alegret M, Munoz E, Monte GC, Alayrach E, Sanchez A et al (2009) Prefrontal cortex volume reduction on MRI in preclinical Huntington’s disease relates to visuomotor performance and CAG number. Parkinsonism Relat Disord 15:213–219CrossRefPubMed

34.

Scahill RI, Hobbs NZ, Say MJ, Bechtel N, Henley SM, Hyare H et al (2013) Clinical impairment in premanifest and early Huntington’s disease is associated with regionally specific atrophy. Hum Brain Mapp 34:519–529PubMed

35.

Henley SM, Ridgway GR, Scahill RI, Kloppel S, Tabrizi SJ, Fox NC et al (2010) Pitfalls in the use of voxel-based morphometry as a biomarker: examples from huntington disease. AJNR Am J Neuroradiol 31:711–719CrossRefPubMed

36.

Lambrecq V, Langbour N, Guehl D, Bioulac B, Burbaud P, Rotgea J-Y (2013) Evolution of brain gray matter loss in Huntington’s disease: a meta-analysis. Eur J Neurol 12:819–825

37.

Dogan I, Eickhoff SB, Schulz JB, Shah NJ, Laird AR, Fox PT et al (2013) Consistent neurodegeneration and its association with clinical progression in Huntington’s disease: a coordinate-based meta-analysis. Neurodegener Dis 12:23–35CrossRefPubMed

38.

Ruocco HH, Bonilha L, Li LM, Lopes-Cendes I, Cendes F (2008) Longitudinal analysis of regional gray matter loss in Huntington disease: effects of the length of the expanded CAG repeat. J Neurol Neurosurg Psychiatry 79:130–135CrossRefPubMed

39.

Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G et al (2012) Potential endpoints for clinical trials in premanifest and early Huntington’s disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurol 11:42–53CrossRefPubMed

40.

Diedrichsen J (2006) A spatially unbiased atlas template of the human cerebellum. Neuroimage 33:127–138CrossRefPubMed

41.

Kuhn S, Romanowski A, Schubert F, Gallinat J (2011) Reduction of cerebellar grey matter in Crus I and II in schizophrenia. Brain Struct Funct 217:523–529CrossRefPubMed

42.

Fox MD, Greicius M (2010) Clinical applications of resting state functional connectivity. Front Syst Neurosci 4:19PubMedCentralPubMed

43.

van den Heuvel MP, Hulshoff Pol HE (2010) Exploring the brain network: a review on resting-state fMRI functional connectivity. Eur Neuropsychopharmacol 20:519–534CrossRefPubMed

44.

Huntington-Study-Group (1996) Unified Huntington’s Disease Rating Scale: reliability and consistency. Mov Disord 11:136–142CrossRef

45.

Wolf RC, Sambataro F, Vasic N, Depping MS, Thomann PA, Landwehrmeyer B et al (2014) Abnormal resting-state connectivity of motor and cognitive networks in early manifest Huntington’s disease. Psychol Med 44:3341–3356CrossRefPubMed

46.

Penney JB Jr, Vonsattel JP, MacDonald ME, Gusella JF, Myers RH (1997) CAG repeat number governs the development rate of pathology in Huntington’s disease. Ann Neurol 41:689–692CrossRefPubMed

47.

Buckner RL, Krienen FM, Yeo BT (2013) Opportunities and limitations of intrinsic functional connectivity MRI. Nat Neurosci 16:832–837CrossRefPubMed

48.

Buckner RL, Krienen FM, Castellanos A, Diaz JC, Yeo BT (2011) The organization of the human cerebellum estimated by intrinsic functional connectivity. J Neurophysiol 106:2322–2345PubMedCentralCrossRefPubMed

49.

Biswal B, Yetkin FZ, Haughton VM, Hyde JS (1995) Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med 34:537–541CrossRefPubMed

50.

Fox MD, Corbetta M, Snyder AZ, Vincent JL, Raichle ME (2006) Spontaneous neuronal activity distinguishes human dorsal and ventral attention systems. Proc Natl Acad Sci USA 103:10046–10051PubMedCentralCrossRefPubMed

51.

Fox MD, Snyder AZ, Vincent JL, Corbetta M, Van Essen DC, Raichle ME (2005) The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc Natl Acad Sci USA 102:9673–9678PubMedCentralCrossRefPubMed

52.

Calhoun VD, Kiehl KA, Pearlson GD (2008) Modulation of temporally coherent brain networks estimated using ICA at rest and during cognitive tasks. Hum Brain Mapp 29:828–838PubMedCentralCrossRefPubMed

53.

Calhoun VD, Adali T, Pekar JJ (2004) A method for comparing group fMRI data using independent component analysis: application to visual, motor and visuomotor tasks. Magn Reson Imaging 22:1181–1191CrossRefPubMed

54.

Ashburner J, Friston KJ (2005) Unified segmentation. Neuroimage 26:839–851CrossRefPubMed

55.

Kuhn S, Romanowski A, Schilling C, Banaschewski T, Barbot A, Barker GJ et al (2012) Manual dexterity correlating with right lobule VI volume in right-handed 14-year-olds. Neuroimage 59:1615–1621CrossRefPubMed

56.

D’Agata F, Caroppo P, Boghi A, Coriasco M, Caglio M, Baudino B et al (2011) Linking coordinative and executive dysfunctions to atrophy in spinocerebellar ataxia 2 patients. Brain Struct Funct 216:275–288CrossRefPubMed

57.

Fan L, Tang Y, Sun B, Gong G, Chen ZJ, Lin X et al (2010) Sexual dimorphism and asymmetry in human cerebellum: an MRI-based morphometric study. Brain Res 1353:60–73CrossRefPubMed

58.

Worsley KJ, Cao J, Paus T, Petrides M, Evans AC (1998) Applications of random field theory to functional connectivity. Hum Brain Mapp 6:364–367CrossRefPubMed

59.

Diedrichsen J, Balsters JH, Flavell J, Cussans E, Ramnani N (2009) A probabilistic MR atlas of the human cerebellum. Neuroimage 46:39–46CrossRefPubMed

60.

Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N et al (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15:273–289CrossRefPubMed

61.

Lui S, Li T, Deng W, Jiang L, Wu Q, Tang H et al (2010) Short-term effects of antipsychotic treatment on cerebral function in drug-naive first-episode schizophrenia revealed by “resting state” functional magnetic resonance imaging. Arch Gen Psychiatry 67:783–792CrossRefPubMed

62.

Nopoulos PC, Aylward EH, Ross CA, Johnson HJ, Magnotta VA, Juhl AR et al (2010) Cerebral cortex structure in prodromal Huntington disease. Neurobiol Dis 40:544–554PubMedCentralCrossRefPubMed

63.

Aylward EH, Nopoulos PC, Ross CA, Langbehn DR, Pierson RK, Mills JA et al (2011) Longitudinal change in regional brain volumes in prodromal Huntington disease. J Neurol Neurosurg Psychiatry 82:405–410PubMedCentralCrossRefPubMed

64.

Bhide PG, Day M, Sapp E, Schwarz C, Sheth A, Kim J et al (1996) Expression of normal and mutant huntingtin in the developing brain. J Neurosci 16:5523–5535PubMed

65.

Henley SM, Wild EJ, Hobbs NZ, Scahill RI, Ridgway GR, Macmanus DG et al (2009) Relationship between CAG repeat length and brain volume in premanifest and early Huntington’s disease. J Neurol 256:203–212CrossRefPubMed

66.

Rosas HD, Hevelone ND, Zaleta AK, Greve DN, Salat DH, Fischl B (2005) Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology 65:745–747CrossRefPubMed

67.

Rosas HD, Salat DH, Lee SY, Zaleta AK, Pappu V, Fischl B et al (2008) Cerebral cortex and the clinical expression of Huntington’s disease: complexity and heterogeneity. Brain 131:1057–1068PubMedCentralCrossRefPubMed

68.

Krienen FM, Buckner RL (2009) Segregated fronto-cerebellar circuits revealed by intrinsic functional connectivity. Cereb Cortex 19:2485–2497PubMedCentralCrossRefPubMed

69.

Robinson FR, Fuchs AF (2001) The role of the cerebellum in voluntary eye movements. Annu Rev Neurosci 24:981–1004CrossRefPubMed

70.

Kloppel S, Draganski B, Siebner HR, Tabrizi SJ, Weiller C, Frackowiak RS (2009) Functional compensation of motor function in pre-symptomatic Huntington’s disease. Brain 132:1624–1632PubMedCentralCrossRefPubMed

71.

Saft C, Schuttke A, Beste C, Andrich J, Heindel W, Pfleiderer B (2008) fMRI reveals altered auditory processing in manifest and premanifest Huntington’s disease. Neuropsychologia 46:1279–1289CrossRefPubMed

72.

Wolf RC, Vasic N, Schonfeldt-Lecuona C, Landwehrmeyer GB, Ecker D (2007) Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington’s disease: evidence from event-related fMRI. Brain 130:2845–2857CrossRefPubMed

73.

Rajah MN, D’Esposito M (2005) Region-specific changes in prefrontal function with age: a review of PET and fMRI studies on working and episodic memory. Brain 128:1964–1983CrossRefPubMed

74.

Dumas EM, van den Bogaard SJ, Hart EP, Soeter RP, van Buchem MA, van der Grond J et al (2014) Reduced functional brain connectivity prior to and after disease onset in Huntington’s disease. Neuroimage Clin 2:377–384CrossRef

75.

Allison T, McCarthy G, Luby M, Puce A, Spencer DD (1996) Localization of functional regions of human mesial cortex by somatosensory evoked potential recording and by cortical stimulation. Electroencephalogr Clin Neurophysiol 100:126–140CrossRefPubMed

76.

Puce A, Constable RT, Luby ML, McCarthy G, Nobre AC, Spencer DD et al (1995) Functional magnetic resonance imaging of sensory and motor cortex: comparison with electrophysiological localization. J Neurosurg 83:262–270CrossRefPubMed

77.

Paradiso S, Turner BM, Paulsen JS, Jorge R, Ponto LL, Robinson RG (2008) Neural bases of dysphoria in early Huntington’s disease. Psychiatry Res 162:73–87PubMedCentralCrossRefPubMed

Titel: Abnormal cerebellar volume and corticocerebellar dysfunction in early manifest Huntington’s disease
verfasst von: Robert Christian Wolf
Philipp Arthur Thomann
Fabio Sambataro
Nadine Donata Wolf
Nenad Vasic
G. Bernhard Landwehrmeyer
Sigurd Dietrich Süßmuth
Michael Orth
Publikationsdatum: 01.04.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Neurology / Ausgabe 4/2015
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-015-7642-6

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

25.04.2024 | Hypotonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abnormal cerebellar volume and corticocerebellar dysfunction in early manifest Huntington’s disease

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2015

An international survey of patients with cervical dystonia

Speech disorders reflect differing pathophysiology in Parkinson’s disease, progressive supranuclear palsy and multiple system atrophy

Clinical routine use of dopamine transporter imaging in 516 consecutive patients

Peripheral neuropathy in a family with Sandhoff disease and SH3TC2 deficiency

Hamsi scoring in the prediction of unfavorable outcomes from tuberculous meningitis: results of Haydarpasa-II study

Pathophysiology of neuropsychiatric disorders: moving forward

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie